Vascular Endothelial Growth Factor (VEGF) Serum Levels Are Associated With Survival in Early Stages of Lung Cancer Patients

AIMEvaluate the serum vascular endothelial growth factor (VEGF) levels in the prognosis of lung cancer patients.METHODSFifty-four serum samples were analyzed for VEGF concentrations (79.3% nonsmall cell lung cancer (NSCLC) and 20.7% small cell lung cancer).RESULTSPatients with serum VEGF-A levels hi...

Full description

Saved in:
Bibliographic Details
Published in:Cancer investigation Vol. 28; no. 4; pp. 393 - 398
Main Authors: Pau, Enrique Carrillo-de Santa, Arias, Fernando Carrillo, Pelaez, Enrique Caso, Trueba, Ignacio Muguruza, Hernández, Ignacio Sánchez, Molina, Gemma María Muñoz, Balsalobre, Ramón Moreno, López, Silvia Sacristán, Gómez-Pinillos, Alejandro, Toledo Lobo, Maria del Val
Format: Journal Article
Language:English
Published: 01-05-2010
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract AIMEvaluate the serum vascular endothelial growth factor (VEGF) levels in the prognosis of lung cancer patients.METHODSFifty-four serum samples were analyzed for VEGF concentrations (79.3% nonsmall cell lung cancer (NSCLC) and 20.7% small cell lung cancer).RESULTSPatients with serum VEGF-A levels higher than the mean of the patients studied (434.93 pg/mL) presented a shorter median survival time than those with lower levels (p =.04), as in patients with NSCLC tumors (p =.04) and in those with stages I-II (p <.05), and high serum VEGF-A levels.CONCLUSIONElevated VEGF serum levels have a negative prognostic impact on survival in NSCLC and early stages of lung cancer patients.
AbstractList AIMEvaluate the serum vascular endothelial growth factor (VEGF) levels in the prognosis of lung cancer patients.METHODSFifty-four serum samples were analyzed for VEGF concentrations (79.3% nonsmall cell lung cancer (NSCLC) and 20.7% small cell lung cancer).RESULTSPatients with serum VEGF-A levels higher than the mean of the patients studied (434.93 pg/mL) presented a shorter median survival time than those with lower levels (p =.04), as in patients with NSCLC tumors (p =.04) and in those with stages I-II (p <.05), and high serum VEGF-A levels.CONCLUSIONElevated VEGF serum levels have a negative prognostic impact on survival in NSCLC and early stages of lung cancer patients.
Author Pau, Enrique Carrillo-de Santa
Toledo Lobo, Maria del Val
Balsalobre, Ramón Moreno
Arias, Fernando Carrillo
Molina, Gemma María Muñoz
López, Silvia Sacristán
Pelaez, Enrique Caso
Gómez-Pinillos, Alejandro
Hernández, Ignacio Sánchez
Trueba, Ignacio Muguruza
Author_xml – sequence: 1
  givenname: Enrique Carrillo-de Santa
  surname: Pau
  fullname: Pau, Enrique Carrillo-de Santa
– sequence: 2
  givenname: Fernando Carrillo
  surname: Arias
  fullname: Arias, Fernando Carrillo
– sequence: 3
  givenname: Enrique Caso
  surname: Pelaez
  fullname: Pelaez, Enrique Caso
– sequence: 4
  givenname: Ignacio Muguruza
  surname: Trueba
  fullname: Trueba, Ignacio Muguruza
– sequence: 5
  givenname: Ignacio Sánchez
  surname: Hernández
  fullname: Hernández, Ignacio Sánchez
– sequence: 6
  givenname: Gemma María Muñoz
  surname: Molina
  fullname: Molina, Gemma María Muñoz
– sequence: 7
  givenname: Ramón Moreno
  surname: Balsalobre
  fullname: Balsalobre, Ramón Moreno
– sequence: 8
  givenname: Silvia Sacristán
  surname: López
  fullname: López, Silvia Sacristán
– sequence: 9
  givenname: Alejandro
  surname: Gómez-Pinillos
  fullname: Gómez-Pinillos, Alejandro
– sequence: 10
  givenname: Maria del Val
  surname: Toledo Lobo
  fullname: Toledo Lobo, Maria del Val
BookMark eNplkEFLwzAcxYNMcJt-AG-5qYdq0iRNchxjm0JBYTqPJab_bpWumUk6GX55O-bN03vwfu8d3ggNWtcCQteU3DNK9AORTEhNiCaME9GbMzSkgqUJpzodoOExT3pAXqBRCJ-EUJVKMUQ_KxNs1xiPZ23p4gaa2jR44d133OC5sdF5fLuaLeZ3eAm-2-Ic9tAEPPGAJyE4W5sIJX6ve3zZ-X297-t1i2fGNwe8jGYNAbsK5127xlPTWvD4xcQa2hgu0XllmgBXfzpGb_PZ6_QxyZ8XT9NJnthUyphwUcqMAlGaZ7rkgmfMypSCFKxSnFOeGiit1jZLlSaZYoSYD0XKimTGKMXYGN2cdnfefXUQYrGtg4WmMS24LhSSMSW0SHlP0hNpvQvBQ1XsfL01_lBQUhx_Lv79zH4Bg_NwPA
CitedBy_id crossref_primary_10_1016_j_ejso_2014_05_014
crossref_primary_10_1007_s13277_014_1628_3
crossref_primary_10_1002_ijc_27441
crossref_primary_10_1016_j_ctrv_2013_02_004
crossref_primary_10_1155_2012_193436
crossref_primary_10_1016_S1470_2045_10_70232_1
crossref_primary_10_1007_s00432_013_1425_1
crossref_primary_10_1089_dna_2013_2249
crossref_primary_10_1007_s10456_014_9433_6
ContentType Journal Article
DBID AAYXX
CITATION
7X8
DOI 10.3109/07357900903405900
DatabaseName CrossRef
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1532-4192
EndPage 398
ExternalDocumentID 10_3109_07357900903405900
GroupedDBID ---
.GJ
00X
03L
0BK
0R~
29B
36B
4.4
53G
5GY
5RE
5VS
6J9
6PF
AALIY
AALUX
AAMIU
AAORF
AAPUL
AAPXX
AAQRR
AAWTL
AAYXX
ABBKH
ABDBF
ABEIZ
ABJNI
ABLIJ
ABLJU
ABLKL
ABUPF
ABWCV
ABXYU
ABZEW
ACENM
ACGEJ
ACGFO
ACGFS
ACIEZ
ACKZS
ADCVX
ADFOM
ADFZZ
ADRBQ
ADXPE
AECIN
AEGXH
AEIIZ
AENEX
AEOZL
AEXWM
AFFNX
AFKVX
AFLEI
AGDLA
AGFJD
AGRBW
AGYJP
AIAGR
AIJEM
AIRBT
AJVHN
AJWEG
AKBVH
ALMA_UNASSIGNED_HOLDINGS
ALQZU
ALYBC
AMDAE
AWYRJ
BABNJ
BLEHA
BOHLJ
BRMBE
CAG
CCCUG
CITATION
COF
CS3
CYYVM
CZDIS
DKSSO
DRXRE
DU5
DWTOO
EAP
EBD
EBS
EJD
EMB
EMK
EMOBN
EPL
ESX
F5P
H13
HZ~
IH2
JENTW
KRBQP
KSSTO
KWAYT
KYCEM
LJTGL
M44
M4Z
NUSFT
O9-
P2P
QQXMO
RNANH
RVRKI
SV3
TBQAZ
TDBHL
TERGH
TFDNU
TFL
TFW
TUROJ
TUS
UDS
UEQFS
V1S
ZGI
ZXP
~1N
7X8
ID FETCH-LOGICAL-c277t-45d761e089469d45463c721e753f844142aedc99c6289068300ab80df06aa8833
ISSN 0735-7907
IngestDate Fri Oct 25 22:20:06 EDT 2024
Thu Nov 21 20:33:41 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c277t-45d761e089469d45463c721e753f844142aedc99c6289068300ab80df06aa8833
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PQID 733859524
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_733859524
crossref_primary_10_3109_07357900903405900
PublicationCentury 2000
PublicationDate 2010-05-01
PublicationDateYYYYMMDD 2010-05-01
PublicationDate_xml – month: 05
  year: 2010
  text: 2010-05-01
  day: 01
PublicationDecade 2010
PublicationTitle Cancer investigation
PublicationYear 2010
SSID ssj0018275
Score 2.0598264
Snippet AIMEvaluate the serum vascular endothelial growth factor (VEGF) levels in the prognosis of lung cancer patients.METHODSFifty-four serum samples were analyzed...
SourceID proquest
crossref
SourceType Aggregation Database
StartPage 393
Title Vascular Endothelial Growth Factor (VEGF) Serum Levels Are Associated With Survival in Early Stages of Lung Cancer Patients
URI https://search.proquest.com/docview/733859524
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtZ3db9MwEMCtbpMQL4hPMQbIDzwAUUTiOF-PVUkZ0lqQlk17i5zEKZVCMiUND_DPcxfHS7o9AA-8RJXrRpXvp_P57nxHyBubF37upZnJAilNnkthpqknTAG2t-Cp8LiN951Pz_31VfAx4tFsppvpjGP_VdIwBrLGm7P_IO2bl8IAfAaZwxOkDs-_kvulTi2VVY63q0p0iW_gsL37NjTXQaPyMvq0RIcA_KXuu1Fi5lBrYBKYGMSls9LbDnTJj74yhyH7YshgTm5Updqywwu7iE2j67O2U2N3ob7ajqU8xpj_QjTNtixrM5fGOUhXYI5ir5irZqsSwffmGXNYu565wfNdjzPa2vgqS6F84bd-v-o2XdP9FEbcdDLtLeXPm0pkKv1M-ztUqH7wd0ito1kfvJ4qcRZMYOUTjeyoBozD5u6olte39w1HlV0Fdef6oYWuK963Ux03SZ0YsP6SLC_OzpI4uooPyBED9Qba9Wi-iNarm-hVwHxXRdDxxR_uvHbfBto3AXq7Jn5IHgwHEjpXJD0iM1k9JvdWQ8rFE_JLA0UnQFEFFFVA0beI0zvaw0QVTBRgoiNMFGGiGia6rWgPE1Uw0bqgCBNVMFEN01NysYzixak5dOwwM-b7O5O7ue_Z0gpC7oU5x1YLmc9sCWfiIgDDmzMh8ywMMw_j217gWJZIAysvLE8IbHv9jBxWdSWfEwp2M0y1pesXBc9TIbgVwrKyQrh4mzo8Ju_1GibXqjBLAgdaXPDkzoIfE6pXOQH1iTExUcm6axPfcbDCH-Mv_jzlhNwfgXxJDncA7ity0Obd64GA30CIk1Y
link.rule.ids 315,782,786,27933,27934
linkProvider Taylor & Francis
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Vascular+endothelial+growth+factor+%28VEGF%29+serum+levels+are+associated+with+survival+in+early+stages+of+lung+cancer+patients&rft.jtitle=Cancer+investigation&rft.au=Carrillo-de+Santa+Pau%2C+Enrique&rft.au=Carrillo+Arias%2C+Fernando&rft.au=Caso+Pelaez%2C+Enrique&rft.au=Muguruza+Trueba%2C+Ignacio&rft.date=2010-05-01&rft.eissn=1532-4192&rft.volume=28&rft.issue=4&rft.spage=393&rft.epage=398&rft_id=info:doi/10.3109%2F07357900903405900&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0735-7907&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0735-7907&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0735-7907&client=summon